This pro-stimulatory effect could also be due, in situ, to MIF secreted by cells from the tumor microenvironment, such as tumor-associated macrophages, tumor-infiltrating lymphocytes, or cancer-associated fibroblasts [29–33]. The gene discussed is MIF; the disease is neoplasm.